Replies to post #12279 on Sorrento Therapeutics Inc (SRNE)

[1776club]

Got my Party hat at the ready. 2022 will be the year of explosive growth for Sorrento. The year 2021 was the lighting of the fuse as Sorrento acquired the equipment to produce COVISTIX and produced and shipped it as their first Commercial product internationally.

[dia76ca]

I know they have to see the safety and efficacy of second generation oncolytic virus Seprehvec in monotherapy...but I look forward to seeing it combined with a second generation systemic anti-CTLA4! This could be amazing! And I wonder how it might work with Abivertinib...a true wonder drug!